Immunomedics Shares Down 23% On Report Of Data Integrity Breach; Hearing Morgan Stanley Has Defended Co./Stock, Suggesting Co. Mgmt. Has Said Issues Were Discovered In Late 2017, 2018
Benzinga Newsdesk